chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling, Swelling, Vaccination site movement impairment
Clinical narrative: feet look like they're swelling a little bit; Thumb, index, and middle finger are really sore; hands have ballooned back up; swelling came back and didnot go away; only able to close hands halfway; swelling; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (only able to close hands halfway), SWELLING (swelling), PERIPHERAL SWELLING (feet look like they're swelling a little bit), PAIN IN EXTREMITY (Thumb, index, and middle finger are really sore) and PERIPHERAL SWELLING (hands have ballooned back up) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included VITAMINS NOS for an unknown indication.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (only able to close hands halfway) and SWELLING (swelling). On an unknown date, the patient experienced PERIPHERAL SWELLING (feet look like they're swelling a little bit), PAIN IN EXTREMITY (Thumb, index, and middle finger are really sore), PERIPHERAL SWELLING (hands have ballooned back up) and SWELLING (swelling came back and didnot go away). The patient was treated with IBUPROFEN ongoing since an unknown date for Swelling, at a dose of 1 dosage form. At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (only able to close hands halfway), SWELLING (swelling), PERIPHERAL SWELLING (feet look like they're swelling a little bit), PAIN IN EXTREMITY (Thumb, index, and middle finger are really sore), PERIPHERAL SWELLING (hands have ballooned back up) and SWELLING (swelling came back and didnot go away) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       On 06-JUL-2021, a caller called on her brother behalf as he is a senior citizen and she is helping him as he is not able to print off a computer. Caller will help him get the form and do whatever is he supposed to do.   This case was linked to MOD-2021-176644 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 10-Jun-2021: Follow-up information received on 10-06-2021 contains non-significant information. On 15-Jun-2021: Patient initials updated. On 06-Jul-2021: Non significant Follow up- Caller called on behalf of her brother as she will help him print off a computer and get the form and do whatever is he supposed to do. Caller contact information were updated.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Off label use
Clinical narrative: patient received second dose on day 20 instead of day 28; This spontaneous case was reported by a pharmacist and describes the occurrence of OFF LABEL USE (patient received second dose on day 20 instead of day 28) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-May-2021, the patient experienced OFF LABEL USE (patient received second dose on day 20 instead of day 28). At the time of the report, OFF LABEL USE (patient received second dose on day 20 instead of day 28) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant information was not reported. Treatment information was not reported.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Tenderness
Clinical narrative: Tenderness in arm; This spontaneous case was reported by a patient and describes the occurrence of TENDERNESS (Tenderness in arm) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037B21A) for COVID-19 vaccination.     The patient's past medical history included Smoker.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, the patient experienced TENDERNESS (Tenderness in arm). At the time of the report, TENDERNESS (Tenderness in arm) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant and treatment information were not reported.   This case was linked to MOD-2021-176293 (Patient Link).; Sender's Comments: Based on current available information and the temporal association between product use and the start date of the event, a causal relationship cannot be excluded.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Given the second dose of the vaccine a week early; This spontaneous case was reported by a health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Given the second dose of the vaccine a week early) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047C21A and 040B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-May-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Given the second dose of the vaccine a week early). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Given the second dose of the vaccine a week early) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant information was not reported. Treatment information was not reported. The action taken with mRNA-1273 with the event was considered as not applicable.    Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: Follow-up document received on 28/5/2021 does not contain any new information
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: tired later in the day; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (tired later in the day) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (tired later in the day). At the time of the report, FATIGUE (tired later in the day) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant information was not reported. Treatment information was not reported.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling
Clinical narrative: hands were swelling every morning, only able to close hands halfway; feet look like they're swelling a little bit; Thumb, index, and middle finger are really sore; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (hands were swelling every morning, only able to close hands halfway), PERIPHERAL SWELLING (feet look like they're swelling a little bit) and PAIN IN EXTREMITY (Thumb, index, and middle finger are really sore) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036B21A and 002B21A) for COVID-19 vaccination.     No medical history reported by reporter.  Concomitant products included VITAMINS NOS for an unknown indication.   On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (hands were swelling every morning, only able to close hands halfway), PERIPHERAL SWELLING (feet look like they're swelling a little bit) and PAIN IN EXTREMITY (Thumb, index, and middle finger are really sore). The patient was treated with IBUPROFEN ongoing since an unknown date for Swelling, at an unspecified dose and frequency; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date for Swelling, at an unspecified dose and frequency and MAGNESIUM SULFATE (EPSOM SALT) ongoing since an unknown date for Swelling, at an unspecified dose and frequency. At the time of the report, PERIPHERAL SWELLING (hands were swelling every morning, only able to close hands halfway) had not resolved and PERIPHERAL SWELLING (feet look like they're swelling a little bit) and PAIN IN EXTREMITY (Thumb, index, and middle finger are really sore) outcome was unknown.            Most recent FOLLOW-UP information incorporated above includes: On 10-Jun-2021: Follow up received, contains non significant information On 15-Jun-2021: Follow up received, contains no significant information On 06-Jul-2021: Non significant follow up - narrative updated as patient stated that she calling on behalf of brother for safety follow-up.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: We had a Moderna vaccine that was going to expire today  (26May2021) at 8:54am, and the vaccine was given 10 minutes after that time; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (We had a Moderna vaccine that was going to expire today  (26May2021) at 8:54am, and the vaccine was given 10 minutes after that time) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included OMEPRAZOLE (PRILOSEC [OMEPRAZOLE]), AMLODIPINE BESILATE (NORVASC), NAPROXEN, GABAPENTIN and SUMATRIPTAN (IMITREX [SUMATRIPTAN]) for an unknown indication.   On 26-May-2021 at 9:04 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (We had a Moderna vaccine that was going to expire today  (26May2021) at 8:54am, and the vaccine was given 10 minutes after that time). At the time of the report, EXPIRED PRODUCT ADMINISTERED (We had a Moderna vaccine that was going to expire today  (26May2021) at 8:54am, and the vaccine was given 10 minutes after that time) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant information was not reported. Treatment information was not reported. The action taken with mRNA-1273 with the event was considered as not applicable.    Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Swelling
Clinical narrative: swelling; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (swelling) and ARTHRALGIA (joint pain) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 043B2IA and 0128AZIA) for COVID-19 vaccination.     No medical history provided.  Concomitant products included FINASTERIDE, ARIPIPRAZOLE (ABILIFY) and SERTRALINE for an unknown indication.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Apr-2021, the patient experienced SWELLING (swelling) and ARTHRALGIA (joint pain). The patient was treated with IBUPROFEN for Joint pain, at an unspecified dose and frequency. At the time of the report, SWELLING (swelling) and ARTHRALGIA (joint pain) outcome was unknown.            This case was linked to MOD-2021-168672 (Patient Link).
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Influenza, Vaccination complication
Clinical narrative: reaction "exactly the same as everybody else's"; "mild flu"; Really tired; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (reaction "exactly the same as everybody else's"), INFLUENZA ("mild flu") and FATIGUE (Really tired) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Asthma.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (reaction "exactly the same as everybody else's"), INFLUENZA ("mild flu") and FATIGUE (Really tired). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, VACCINATION COMPLICATION (reaction "exactly the same as everybody else's"), INFLUENZA ("mild flu") and FATIGUE (Really tired) outcome was unknown.            The action taken with mRNA-1273 with the event was considered as not applicable. Concomitant information was not reported.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Asthenia, Dizziness, Headache, Myalgia
Clinical narrative: Abdominal pain; General weakness; Body aches; Headache; Feverishess; Dizziness; Chest tickling/ itchiness; Throat tickle; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), PRURITUS (Chest tickling/ itchiness), THROAT IRRITATION (Throat tickle), ABDOMINAL PAIN (Abdominal pain) and ASTHENIA (General weakness) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037CZ1A and 044BR1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Anxiety on 02-Oct-2009 and Bipolar depression on 02-Oct-2009. Concurrent medical conditions included Allergy to chemicals (sensitivity to MSG (monosodium glutamate)). Concomitant products included ARIPIPRAZOLE (ABILIFY) from 15-Dec-2009 to an unknown date for Mood alteration NOS, SERTRALINE HYDROCHLORIDE (ZOLOFT) from 15-Dec-2009 to an unknown date and TAZAROTENE (TAZORAC) from 01-Jan-2021 to an unknown date for an unknown indication.   On 20-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient experienced PRURITUS (Chest tickling/ itchiness) and THROAT IRRITATION (Throat tickle). On 19-May-2021, the patient experienced DIZZINESS (Dizziness). On an unknown date, the patient experienced ABDOMINAL PAIN (Abdominal pain), ASTHENIA (General weakness), MYALGIA (Body aches), HEADACHE (Headache) and PYREXIA (Feverishess). At the time of the report, DIZZINESS (Dizziness), PRURITUS (Chest tickling/ itchiness), THROAT IRRITATION (Throat tickle), ABDOMINAL PAIN (Abdominal pain), ASTHENIA (General weakness), MYALGIA (Body aches), HEADACHE (Headache) and PYREXIA (Feverishess) outcome was unknown. Not Provided          Treatment medications was not reported. Action taken with mRNA-1273 in response to the events was not applicable.   This case was linked to MOD-2021-082924 (Patient Link).
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Pyrexia, Throat irritation
Clinical narrative: Abdominal pain; General weakness; Body aches; Headache; Feverishess; Dizziness; Chest tickling/ itchiness; Throat tickle; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), PRURITUS (Chest tickling/ itchiness), THROAT IRRITATION (Throat tickle), ABDOMINAL PAIN (Abdominal pain) and ASTHENIA (General weakness) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037CZ1A and 044BR1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Anxiety on 02-Oct-2009 and Bipolar depression on 02-Oct-2009. Concurrent medical conditions included Allergy to chemicals (sensitivity to MSG (monosodium glutamate)). Concomitant products included ARIPIPRAZOLE (ABILIFY) from 15-Dec-2009 to an unknown date for Mood alteration NOS, SERTRALINE HYDROCHLORIDE (ZOLOFT) from 15-Dec-2009 to an unknown date and TAZAROTENE (TAZORAC) from 01-Jan-2021 to an unknown date for an unknown indication.   On 20-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient experienced PRURITUS (Chest tickling/ itchiness) and THROAT IRRITATION (Throat tickle). On 19-May-2021, the patient experienced DIZZINESS (Dizziness). On an unknown date, the patient experienced ABDOMINAL PAIN (Abdominal pain), ASTHENIA (General weakness), MYALGIA (Body aches), HEADACHE (Headache) and PYREXIA (Feverishess). At the time of the report, DIZZINESS (Dizziness), PRURITUS (Chest tickling/ itchiness), THROAT IRRITATION (Throat tickle), ABDOMINAL PAIN (Abdominal pain), ASTHENIA (General weakness), MYALGIA (Body aches), HEADACHE (Headache) and PYREXIA (Feverishess) outcome was unknown. Not Provided          Treatment medications was not reported. Action taken with mRNA-1273 in response to the events was not applicable.   This case was linked to MOD-2021-082924 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received vaccination with a vial that had been punctured for 31 hours; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received vaccination with a vial that had been punctured for 31 hours) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received vaccination with a vial that had been punctured for 31 hours). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received vaccination with a vial that had been punctured for 31 hours) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant product use was provided by the reporter. No treatment medication was provided.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022C21A and 039B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-May-2021, the patient experienced RASH (Rash). At the time of the report, RASH (Rash) outcome was unknown.            Concomitant information was not reported. Treatment information was not reported. The action taken with mRNA-1273 with the event was considered as not applicable.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Received expired dose of vaccine that had exceeded the 30 day refrigeration limit; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received expired dose of vaccine that had exceeded the 30 day refrigeration limit) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received expired dose of vaccine that had exceeded the 30 day refrigeration limit). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received expired dose of vaccine that had exceeded the 30 day refrigeration limit) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant information was not reported. Treatment information was not reported. The action taken with mRNA-1273 with the event was considered as not applicable.   Reporter did not allow further contact
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Dysphemia, Influenza, Pain in extremity
Clinical narrative: your typical flu; sore arm; stutter; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (your typical flu), PAIN IN EXTREMITY (sore arm) and DYSPHEMIA (stutter) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040A21A and 031L20A) for COVID-19 vaccination.     Concomitant products included AMLODIPINE, HYDROCHLOROTHIAZIDE, POTASSIUM, MAGNESIUM, GABAPENTIN, FAMOTIDINE, ASCORBIC ACID, TOCOPHERYL ACETATE, XANTOFYL, ZEAXANTHIN, ZINC (AREDS), MIRABEGRON (MYRBETRIQ) and ESTRADIOL for an unknown indication.   On 17-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INFLUENZA (your typical flu), PAIN IN EXTREMITY (sore arm) and DYSPHEMIA (stutter). At the time of the report, INFLUENZA (your typical flu), PAIN IN EXTREMITY (sore arm) and DYSPHEMIA (stutter) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not reported. The action taken with mRNA-1273 with the event was considered as not applicable.
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: side effects on arm; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (side effects on arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for an unknown indication.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (side effects on arm). At the time of the report, PAIN IN EXTREMITY (side effects on arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Med Info Agent:  Mother had some side effects on arm, she is working with her doctor for side effects.  Consent for Safety follow up not given.
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Headache, Pyrexia
Clinical narrative: intense pressure headache in forehead and face; Fever; Diarrhea; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DIARRHOEA (Diarrhea), HEADACHE (intense pressure headache in forehead and face) and PYREXIA (Fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040A21A and 007B21A) for COVID-19 vaccination.     Medical history was not reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Apr-2021, the patient experienced DIARRHOEA (Diarrhea) and PYREXIA (Fever). On 26-Apr-2021, the patient experienced HEADACHE (intense pressure headache in forehead and face). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at a dose of 1 dosage form. At the time of the report, DIARRHOEA (Diarrhea) and PYREXIA (Fever) had resolved and HEADACHE (intense pressure headache in forehead and face) had not resolved.            No concomitant medications were reported. Action taken with mRNA-1273 in response to the event was not applicable.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: received doses from vials that had exceeded the 30 day refrigeration limit; received doses from vials that had exceeded the 30 day refrigeration limit; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT STORAGE ERROR (received doses from vials that had exceeded the 30 day refrigeration limit) and EXPIRED PRODUCT ADMINISTERED (received doses from vials that had exceeded the 30 day refrigeration limit) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 25-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-May-2021, the patient experienced PRODUCT STORAGE ERROR (received doses from vials that had exceeded the 30 day refrigeration limit). On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (received doses from vials that had exceeded the 30 day refrigeration limit). At the time of the report, PRODUCT STORAGE ERROR (received doses from vials that had exceeded the 30 day refrigeration limit) and EXPIRED PRODUCT ADMINISTERED (received doses from vials that had exceeded the 30 day refrigeration limit) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant information was not reported. Treatment information was not reported. The action taken with mRNA-1273 with the event was considered as not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: some rash firming on both of her arms; This spontaneous case was reported by a consumer and describes the occurrence of RASH (some rash firming on both of her arms) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.   On 26-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-May-2021, the patient experienced RASH (some rash firming on both of her arms). At the time of the report, RASH (some rash firming on both of her arms) outcome was unknown.            Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure measurement, Breath sounds, Fatigue, Heart rate, Oxygen saturation
Clinical narrative: sore arm; fatigue; This spontaneous case was reported by a nurse and describes the occurrence of PAIN IN EXTREMITY (sore arm) and FATIGUE (fatigue) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     The patient's past medical history included Vagus nerve disorder NOS (exaggerated vagus nerve response about 20 years ago) and Back surgery (Patient had back surgery in 2009). Concomitant products included CENTRUM FORTE for an unknown indication.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and FATIGUE (fatigue). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 22-Apr-2021, PAIN IN EXTREMITY (sore arm) and FATIGUE (fatigue) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: 116/70 (Inconclusive) 116/70. On an unknown date, Breath sounds: 18 (Inconclusive) 18 and little labored (good). On an unknown date, Heart rate: 72 regular (normal) 72 regular. On an unknown date, Oxygen saturation: 99 (Inconclusive) O2 sat = not available at the time of muscle spasm/contraction but 30 mins later was able to get an 02 sat = 99..     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-176571 (Patient Link).
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; fatigue; This spontaneous case was reported by a nurse and describes the occurrence of PAIN IN EXTREMITY (sore arm) and FATIGUE (fatigue) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     The patient's past medical history included Vagus nerve disorder NOS (exaggerated vagus nerve response about 20 years ago) and Back surgery (Patient had back surgery in 2009). Concomitant products included CENTRUM FORTE for an unknown indication.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and FATIGUE (fatigue). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 22-Apr-2021, PAIN IN EXTREMITY (sore arm) and FATIGUE (fatigue) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: 116/70 (Inconclusive) 116/70. On an unknown date, Breath sounds: 18 (Inconclusive) 18 and little labored (good). On an unknown date, Heart rate: 72 regular (normal) 72 regular. On an unknown date, Oxygen saturation: 99 (Inconclusive) O2 sat = not available at the time of muscle spasm/contraction but 30 mins later was able to get an 02 sat = 99..     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-176571 (Patient Link).
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Device connection issue, Underdose, Vaccination site haemorrhage
Clinical narrative: A little of the vaccine and blood ran down the patients arm. (left); She states as the tech pulled the syringe back the needle detached and remined in the patient's arm; vaccine underdose; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE HAEMORRHAGE (A little of the vaccine and blood ran down the patients arm. (left)), DEVICE CONNECTION ISSUE (She states as the tech pulled the syringe back the needle detached and remined in the patient's arm) and UNDERDOSE (vaccine underdose) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050Z21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-May-2021, the patient experienced VACCINATION SITE HAEMORRHAGE (A little of the vaccine and blood ran down the patients arm. (left)), DEVICE CONNECTION ISSUE (She states as the tech pulled the syringe back the needle detached and remined in the patient's arm) and UNDERDOSE (vaccine underdose). On 26-May-2021, VACCINATION SITE HAEMORRHAGE (A little of the vaccine and blood ran down the patients arm. (left)), DEVICE CONNECTION ISSUE (She states as the tech pulled the syringe back the needle detached and remined in the patient's arm) and UNDERDOSE (vaccine underdose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant information was provided by the reporter.  No treatment information was provided.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Has not received the second dose (13Jan2021 was first dose); This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Has not received the second dose (13Jan2021 was first dose)) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On 26-May-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Has not received the second dose (13Jan2021 was first dose)). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Has not received the second dose (13Jan2021 was first dose)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not provided.  Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: inappropriate schedule of vaccine administered; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (inappropriate schedule of vaccine administered) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (inappropriate schedule of vaccine administered). On 27-Apr-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (inappropriate schedule of vaccine administered) had resolved.            No concomitant information was provided by the reporter.  No treatment information was provided.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Heart rate increased
Clinical narrative: Chills; Fatigue; This spontaneous case was reported by a patient and describes the occurrence of CHILLS (Chills) and FATIGUE (Fatigue) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-May-2021, the patient experienced CHILLS (Chills) and FATIGUE (Fatigue). At the time of the report, CHILLS (Chills) and FATIGUE (Fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-May-2021, Heart rate increased: 140 (High) she experienced a fast heart beat. She said it got up to 140bpm..         No concomitant information was provided by the reporter.  No treatment information was provided.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Received Expired Dose of Vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received Expired Dose of Vaccine) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received Expired Dose of Vaccine). On 25-May-2021, EXPIRED PRODUCT ADMINISTERED (Received Expired Dose of Vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication information was given.  No Treatment medication information was given.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Received Expired Dose of Vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received Expired Dose of Vaccine) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received Expired Dose of Vaccine). On 25-May-2021, EXPIRED PRODUCT ADMINISTERED (Received Expired Dose of Vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant information was provided by the reporter.  No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Varicella
Clinical narrative: Got Chicken pox; This spontaneous case was reported by a consumer and describes the occurrence of VARICELLA (Got Chicken pox) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VARICELLA (Got Chicken pox). At the time of the report, VARICELLA (Got Chicken pox) outcome was unknown.            No concomitant medications provided  No treatment medications provided
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: have been vaccinated with the Moderna, last week, and i am being called 7 days after, to have; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (have been vaccinated with the Moderna, last week, and i am being called 7 days after, to have) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (have been vaccinated with the Moderna, last week, and i am being called 7 days after, to have). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (have been vaccinated with the Moderna, last week, and i am being called 7 days after, to have) had resolved.            No concomitant medication included.  No treatment medication included.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Psoriasis
Clinical narrative: itching continued; thought she had psoriasis; "itching in my hairline, back of neck, and hives"; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS ("itching in my hairline, back of neck, and hives"), PRURITUS (itching continued) and PSORIASIS (thought she had psoriasis) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included AMLODIPINE and METOPROLOL for Blood pressure, PRAVASTATIN for High cholesterol, FAMOTIDINE, CALCIUM and VITAMIN D [VITAMIN D NOS] for an unknown indication.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 06-Feb-2021, the patient experienced PRURITUS ("itching in my hairline, back of neck, and hives"). On 04-Mar-2021, the patient experienced PRURITUS (itching continued) and PSORIASIS (thought she had psoriasis). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency and TRIAMCINOLONE at an unspecified dose and frequency. At the time of the report, PRURITUS ("itching in my hairline, back of neck, and hives") had resolved and PRURITUS (itching continued) and PSORIASIS (thought she had psoriasis) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   On 04 Mar 2021, the patient was seen by a physician for her rash.   This case was linked to MOD-2021-176888 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 09-Jul-2021: Follow up received, updated event outcome for itching  was recovered
Sex: F
Vaccine: COVID19
Symptoms: Migraine
Clinical narrative: daily migraine; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MIGRAINE (daily migraine) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016B21A and 040A21A) for COVID-19 vaccination.     Concurrent medical conditions included Chronic migraine since 1956. Concomitant products included FLUOXETINE from 2000 to an unknown date and SUMATRIPTAN (IMITREX [SUMATRIPTAN]) from 2005 to an unknown date for an unknown indication.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 1. On 10-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MIGRAINE (daily migraine). The patient was treated with PARACETAMOL (TYLENOL) for Migraine, at a dose of 1 dosage form. On 30-Apr-2021, MIGRAINE (daily migraine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Dysphemia
Clinical narrative: stutter, a terrible stutter; This spontaneous case was reported by a patient and describes the occurrence of DYSPHEMIA (stutter, a terrible stutter) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040A21A and 031L20A) for COVID-19 vaccination.     The patient's past medical history included No Adverse Events and COVID-19 pneumonia on 03-Nov-2020. Concurrent medical conditions included Heart disease, unspecified. Concomitant products included AMLODIPINE and hydrochlorthiazide for Heart disease, unspecified, POTASSIUM, MAGNESIUM, GABAPENTIN, FAMOTIDINE, ASCORBIC ACID, TOCOPHERYL ACETATE, XANTOFYL, ZEAXANTHIN, ZINC (AREDS), MIRABEGRON (MYRBETRIQ) and ESTRADIOL for an unknown indication.   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DYSPHEMIA (stutter, a terrible stutter). At the time of the report, DYSPHEMIA (stutter, a terrible stutter) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided by the reporter   This case was linked to MOD-2021-176747 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Fibromyalgia
Clinical narrative: Worst Fibromyalgia Pain after vaccination; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of FIBROMYALGIA (Worst Fibromyalgia Pain after vaccination) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Fibromyalgia.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FIBROMYALGIA (Worst Fibromyalgia Pain after vaccination). At the time of the report, FIBROMYALGIA (Worst Fibromyalgia Pain after vaccination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.   ? No treatment information was provided.  It was reported that a group of patients having fibromyalgia experienced event.  Cross-Linked with Case numbers: MOD21-079869 & MOD21-097145.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: first dose Pfizer, second dose Moderna; This spontaneous case was reported by a consumer and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (first dose Pfizer, second dose Moderna) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (first dose Pfizer, second dose Moderna). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (first dose Pfizer, second dose Moderna) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.